Medtronic PLC is close to rethinking its business strategy for its persistently struggling U.S. spine unit, says CEO Omar Ishrak.
“While we continue to believe in the potential of this market, we urgently need to see meaningful signs of improvement from our current initiatives,” Ishrak said during the firm’s fiscal third-quarter earnings call Feb. 21
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?